
3.61 Delayed Data As of Jan 22 | ![]() Today’s Change | 1.80 Today|||52-Week Range 4.54 | +43.25% Year-to-Date |
Previous close | 3.60 |
Today’s open | 3.51 |
Day’s range | 3.43 - 3.64 |
Volume | 99,350 |
Average volume (3 months) | 1,899,719 |
Market cap | $775.7M |
Earnings growth (last year) | -43.55% |
Earnings growth (this year) | +46.96% |
Earnings growth (next 5 years) | -- |
Revenue growth (last year) | -100.00% |
P/E ratio | NM |
Price/Sales | -- |
Price/Book | 6.93 |
Today’s change | Today’s % change | |
---|---|---|
VXRTVaxart Inc | +0.13 | +1.87% |
PRVLPrevail Therapeutics... | 0.00 | 0.00% |
RUBYRubius Therapeutics ... | +0.25 | +2.71% |
SYRSSyros Pharmaceutical... | -0.06 | -0.49% |
Next reporting date | March 4, 2021 |
EPS forecast (this quarter) | -$0.10 |
Annual revenue (last year) | $0.00 |
Annual profit (last year) | -$117.8M |
Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Boston, Massachusetts |